Analyze Diet
Journal of the American Veterinary Medical Association2011; 238(10); 1305-1315; doi: 10.2460/javma.238.10.1305

α-Melanocyte–stimulating hormone and adrenocorticotropin concentrations in response to thyrotropin-releasing hormone and comparison with adrenocorticotropin concentration after domperidone administration in healthy horses and horses with pituitary pars intermedia dysfunction.

Abstract: To compare endogenous ACTH and α-melanocyte-stimulating hormone (α-MSH) concentrations after administration of thyrotropin-releasing hormone (TRH) and to compare ACTH concentrations after TRH administration with those following domperidone administration in healthy horses and horses with pituitary pars intermedia dysfunction (PPID). Methods: Prospective case series. Methods: 69 clinically normal horses and 47 horses with or suspected to have PPID. Methods: ACTH concentrations were measured during 108 TRH stimulation tests in 88 horses, and α-MSH concentrations were measured during 56 TRH stimulation tests in 50 horses. In 28 of these horses, ACTH concentrations after domperidone administration were measured and test results were compared. The pituitary gland was histologically examined in all horses that were euthanatized. Results: ACTH and α-MSH concentrations increased in all horses after TRH administration, with a greater and more prolonged increase in horses with PPID. Percentage increase was significantly greater for α-MSH concentration than for ACTH concentration. The change in ACTH concentration after domperidone administration was less consistent in differentiating clinically normal horses from those with PPID than was the response to TRH. Conclusions: Results suggested that ACTH concentration in response to TRH administration was useful for the diagnosis of PPID in horses and appeared more accurate than response to domperidone administration. Use of an α-MSH concentration ≥ 30 or 50 pmol/L did not appear superior to use of an ACTH concentration ≥ 36 pg/mL for the diagnosis of PPID, either before or 30 minutes after TRH administration.
Publication Date: 2011-05-17 PubMed ID: 21568777DOI: 10.2460/javma.238.10.1305Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research compared the release of two hormones (ACTH and α-MSH) in response to the administration of the thyroid-releasing hormone (TRH) and the release of ACTH after the administration of domperidone in healthy horses and those suffering from pituitary pars intermedia dysfunction (PPID). The study found that measuring the ACTH levels in response to TRH was a more accurate way to diagnose PPID in horses than using domperidone.

Research Aim and Methodology

  • The researchers aimed to compare the concentration of Adrenocorticotropic hormone (ACTH) and α-Melanocyte–stimulating hormone (α-MSH) released in reaction to the administration of thyrotropin-releasing hormone (TRH).
  • They also wanted to compare the concentration of ACTH after administering TRH with that after administering domperidone in two sets of horses – healthy horses and those with pituitary pars intermedia dysfunction (PPID).
  • For this study, they selected 69 normal horses and 47 horses with suspected or confirmed PPID.
  • ACTH concentrations were measured in 88 horses during a total of 108 TRH stimulation tests, while α-MSH concentration was measured in 56 such tests conducted on 50 horses.
  • In 28 horses, ACTH concentration was also measured following domperidone administration.

Findings and Conclusions

  • In the research results, it was found that both ACTH and α-MSH concentrations saw an increase in all horses after TRH administration, but horses with PPID had a more substantial increase.
  • The researchers noted that the percentage increase was higher for α-MSH concentration than ACTH.
  • However, the change in ACTH concentration after domperidone administration was less indicative of the distinction between normal horses and those with PPID.
  • In conclusion, the research suggests that testing the ACTH concentration after administering TRH is a more accurate marker for diagnosing PPID when compared to the response after domperidone administration.
  • Essentially, an α-MSH concentration of ≥ 30 or 50 pmol/L was found to be not superior to an ACTH concentration of ≥ 36 pg/mL for diagnosing PPID in horses, either before or half an hour after TRH administration.

Cite This Article

APA
Beech J, McFarlane D, Lindborg S, Sojka JE, Boston RC. (2011). α-Melanocyte–stimulating hormone and adrenocorticotropin concentrations in response to thyrotropin-releasing hormone and comparison with adrenocorticotropin concentration after domperidone administration in healthy horses and horses with pituitary pars intermedia dysfunction. J Am Vet Med Assoc, 238(10), 1305-1315. https://doi.org/10.2460/javma.238.10.1305

Publication

ISSN: 0003-1488
NlmUniqueID: 7503067
Country: United States
Language: English
Volume: 238
Issue: 10
Pages: 1305-1315

Researcher Affiliations

Beech, Jill
  • Department of Clinical Studies, New Bolton Center, School of Veterinary Medicine, University of Pennsylvania, Kennett Square, PA 19348, USA. jbeech@vet.upenn.edu
McFarlane, Dianne
    Lindborg, Sue
      Sojka, Janice E
        Boston, Raymond C

          MeSH Terms

          • Adrenocorticotropic Hormone / blood
          • Animals
          • Domperidone / pharmacology
          • Dopamine Antagonists / pharmacology
          • Hormones / pharmacology
          • Horse Diseases / blood
          • Horses
          • Pituitary Diseases / blood
          • Pituitary Diseases / metabolism
          • Pituitary Diseases / veterinary
          • Pituitary Gland, Intermediate
          • Thyrotropin-Releasing Hormone / pharmacology
          • alpha-MSH / blood

          Citations

          This article has been cited 8 times.
          1. Drozdzewska K, Gehlen H. Markers for internal neoplasia in the horse.. Vet Med Sci 2023 Jan;9(1):132-143.
            doi: 10.1002/vms3.1042pubmed: 36495211google scholar: lookup
          2. Kirkwood NC, Hughes KJ, Stewart AJ. Prospective Case Series of Clinical Signs and Adrenocorticotrophin (ACTH) Concentrations in Seven Horses Transitioning to Pituitary Pars Intermedia Dysfunction (PPID).. Vet Sci 2022 Oct 17;9(10).
            doi: 10.3390/vetsci9100572pubmed: 36288186google scholar: lookup
          3. Kirkwood NC, Hughes KJ, Stewart AJ. Pituitary Pars Intermedia Dysfunction (PPID) in Horses.. Vet Sci 2022 Oct 10;9(10).
            doi: 10.3390/vetsci9100556pubmed: 36288169google scholar: lookup
          4. Hinrichsen SL, Yuen KY, Dryburgh EL, Bertin FR, Stewart AJ. Short-Term Effects of Temperature and Thyrotropin-Releasing Hormone Stimulation on Adrenocorticotropin Stability in Horses.. Animals (Basel) 2022 Jan 28;12(3).
            doi: 10.3390/ani12030324pubmed: 35158648google scholar: lookup
          5. Thane K, Uricchio C, Frank N. Effect of early or late blood sampling on thyrotropin releasing hormone stimulation test results in horses.. J Vet Intern Med 2022 Mar;36(2):770-777.
            doi: 10.1111/jvim.16362pubmed: 35049089google scholar: lookup
          6. Horn R, Stewart AJ, Jackson KV, Dryburgh EL, Medina-Torres CE, Bertin FR. Clinical implications of using adrenocorticotropic hormone diagnostic cutoffs or reference intervals to diagnose pituitary pars intermedia dysfunction in mature horses.. J Vet Intern Med 2021 Jan;35(1):560-570.
            doi: 10.1111/jvim.16017pubmed: 33368633google scholar: lookup
          7. Horn R, Bertin FR. Evaluation of combined testing to simultaneously diagnose pituitary pars intermedia dysfunction and insulin dysregulation in horses.. J Vet Intern Med 2019 Sep;33(5):2249-2256.
            doi: 10.1111/jvim.15617pubmed: 31498947google scholar: lookup
          8. Rendle DI, Duz M, Beech J, Parkin T, Durham AE. Investigation of single and paired measurements of adrenocorticotropic hormone for the diagnosis of pituitary pars intermedia dysfunction in horses.. J Vet Intern Med 2015 Jan;29(1):355-61.
            doi: 10.1111/jvim.12489pubmed: 25312676google scholar: lookup